Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 12 Breast Neoplasms 7 Neoplasm Metastasis 5 Lymphoma 5 Multiple Myeloma 4 Leukemia 4 Hematologic Neoplasms 4 Colorectal Neoplasms 4 Prostatic Neoplasms 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Depression 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Ovarian Neoplasms 2 Motor Activity 2 Malignant Female Reproductive System Neoplasm 2 Glioblastoma 2 Fatigue 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Caregiver Burden 2 Anxiety Disorders 2 Advanced Malignant Solid Neoplasm 2 Thyroid Neoplasms 1 Stroke 1 Stress Disorders, Post-Traumatic 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Initiation and Maintenance Disorders 1 Signs and Symptoms 1

Interventions

pembrolizumab 243 Carboplatin 211 Pemetrexed 177 Cisplatin 131 Paclitaxel 113 Nivolumab 101 Docetaxel 87 osimertinib 85 durvalumab 78 Specimen Handling 56 atezolizumab 55 Gemcitabine 52 Drug Therapy 52 Magnetic Resonance Spectroscopy 50 Radiosurgery 48 Radiotherapy 47 Ipilimumab 41 130-nm albumin-bound paclitaxel 39 cemiplimab 38 Bevacizumab 34 Cetuximab 30 tislelizumab 29 amivantamab 22 Taxes 22 Platinum Compounds 20 Blood Specimen Collection 20 Immunotherapy 18 Immune Checkpoint Inhibitors 18 Radiation 17 Erlotinib Hydrochloride 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Palliative Care × 1 year × Clear all

NCT07467863 2026-03-12

DUO-NK-NSCLC

Beijing Biotech

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡